ADVOCATING FOR AUSTRALIAN CHILDREN LIVING WITH VISION IMPAIRMENT
Australian Childhood Vision Impairment Register
With
Dr Susan Silveira
Chief Investigator
Australian Childhood Vision Impairment Register, NextSense &
Program Director
Master of Disability Studies (Macquarie University), NextSense
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney | June 2025
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
Currently in Australia, we don’t know how many Australian children have vision impairment.
This makes it hard to plan for the services these children need, or to argue for research into preventing conditions which cause vision impairment.
NextSense Institute, in partnership with key Australian service providers, corporate donors, government departments and health professionals, has undertaken a major research project to develop and maintain an Australia-wide record of children with vision impairment.
This project is called the Australian Childhood Vision Impairment Register.
Australian Health Journal spoke with Dr Susan Silveira, Chief Investigator of the Register.
The Register collects accurate information on children who have been diagnosed by an ophthalmologist (eye doctor) with vision impairment.. This information is used to establish the number of children with vision impairment, the causes and level of vision impairment and any additional disabilities and health conditions these children have.
The Parent or guardian of a child, aged 0-18 years, who has been diagnosed by an ophthalmologist with vision impairment, are invited to join the Australian Childhood Vision Impairment Register.
The Australian Childhood Vision Impairment Register (ACVIR) is sponsored by NextSense with support from Guide Dogs, Vision Australia, low vision service providers and families of children with vision loss.
Source: Written by AUDIENCED sourced from NextSense website
-
Lower back pain presentations in Emergency Department
Around 70 percent of people will experience lower back pain at some stage of their lives.
A recent study conducted over five years found one in three people suffering from lower back pain presented to hospital via an ambulance.In many cases people will attend an emergency department when they feel they can’t manage their pain or when treatments by community healthcare services have been ineffective or inaccessible due to location or cost. However, 90 per cent of people can get better on their own in a few weeks.
-
Cardinal Health brings device reprocessing plant to Australia
Cardinal Health is global medical products manufacturer and leading provider of single-use device reprocessing services in the U.S. In Australia and New Zealand, as one of the largest suppliers of medical devices, announced on 23 May 2024 that it will be opening a single-use medical device reprocessing facility in Australia – its first reprocessing facility outside the United States.
On 18 March 2025 at the Health Innovation Living Lab at the John Hunter Hospital, a further announcement was made, on the chosen single-use medical device remanufacturing facility in Beresfield, Newcastle, set to commence operation late 2025, supported by the NSW Department of Primary Industries and Regional Development.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
